BridgeMD
New treatment option for Prehabilitation
Official title Prehabilitation With Resistance-exercise Training for Breast Cancer Neoadjuvant Therapy
ClinicalTrials.gov ID: NCT06309290
What this study is testing
- What it's testing
- Breast cancer stands as the foremost cause of cancer-related deaths among women worldwide, with the highest incidence of any cancer type. The choice of therapeutic interventions hinges upon factors like cancer stage, cell subtype, and tumor size.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults, women only. Healthy volunteers may be eligible.
You may be able to join if
- Postmenopausal women with breast cancer in stages I, II and III with luminal breast tumor, HER2+ or TNBC
- Indication for neoadjuvant chemotherapy
- Candidates for curative breast surgery
- Body mass index: 18.5 \<BMI \<30 kg/m2
- Sedentary (does not perform scheduled or planned physical activity ≥ 2 times a week)
You likely can't join if
- Present comorbidities that interact with the metabolism and mobility of the muscles of the body and that do not allow the (safe) performance of...
- Severe or uncontrolled cardiovascular disease, cardiac ejection fraction less than 50%
- Previous antineoplastic treatment
- Use of nutritional supplements (leucine, glutamine, casein, whey protein, fatty acids and creatine).
See the full eligibility criteria
- Postmenopausal women with breast cancer in stages I, II and III with luminal breast tumor, HER2+ or TNBC
- Indication for neoadjuvant chemotherapy
- Candidates for curative breast surgery
- Body mass index: 18.5 \<BMI \<30 kg/m2
- Sedentary (does not perform scheduled or planned physical activity ≥ 2 times a week)
- Willingness to participate in the study and follow the proposed prehabilitation scheme.
- Present comorbidities that interact with the metabolism and mobility of the muscles of the body and that do not allow the (safe) performance of strength exercises (e.g., debilitating arthritis, all neurological...
- Severe or uncontrolled cardiovascular disease, cardiac ejection fraction less than 50%
- Previous antineoplastic treatment
- Use of nutritional supplements (leucine, glutamine, casein, whey protein, fatty acids and creatine).
The study team makes the final eligibility decision.
Where it's taking place
- Santiago, Chile
- Temuco, Chile
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, not specified. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Santiago, Chile; Temuco, Chile. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.